EUVIMEDEUVIMED entdecken
Crossref

Risk beyond neutropenia: insights into neutrophil migration from newly diagnosed AML until late after allogeneic stem cell transplantation

Zülal Cibir, Alexander Beer, Andreas Kraus, Aleksandra Pillibeit, Dana Bludau, Haji Abdulla, Nina Rosa Neuendorff, Justin Sonneck, Lennart Kowitz, Stefanie Riese, Ali Ata Tuz, Jianxu Chen und 5 weitere

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiae250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Zülal Cibir und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental Immunology and Imaging, University Hospital Essen, University of Duisburg-Essen, Essen, 45141 Essen, Germany. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Neutrophils, Neutropenia, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen, Der Regierende Bürgermeister von Berlin, Senatskanzlei Wissenschaft und Forschung.ˮ.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantification of neutrophil counts is the most relevant assessment of cellular immunity in clinical practice. Patients with neutropenia are considered at risk and are categorized according to its severity. The incidence of febrile neutropenia varies, but patients with acute myeloid leukemia are traditionally considered at high risk, especially following myelotoxic treatments. To provide additional functional parameters, we investigated the ex vivo migration properties and morphology of neutrophils in 10 patients with acute myeloid leukemia using single-cell video-microscopy and discovered, in addition to neutropenia, highly pathological neutrophil migration patterns and polarization defects in patients with untreated acute myeloid leukemia. Neutrophil speed was the most sensitive parameter and significantly lower at leukemia diagnosis (9.067 vs 15.810 µm/min, P = 0.0025) compared to healthy controls (n = 46). Hematological remission was associated with improved neutrophil migration profiles, but these ultimately normalized only after hematopoietic cell transplantation. Five patients were followed up for long-term effects of hematopoietic cell transplantation for up to 24 mo. This is the first longitudinal ex vivo neutrophil migration study in patients with acute myeloid leukemia, followed by allogeneic hematopoietic cell transplantation. It identified functional neutrophil impairments beyond routine quantitative assessments, adding to the well-known quantitative impairment of neutropenia. HCT can reestablish functional neutrophils with healthy migration profiles in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteNeutrophilsNeutropeniaHematopoietic Stem Cell TransplantationCell MovementHumansMaleFemaleMiddle AgedAdultTransplantation, HomologousAgedYoung Adult

Stichwörter der Autor:innen

acute myeloid leukemiamyeloid neoplasianeutrophil granulocytestransplantation

Autor:innen und Institutionen

  • Institute for Experimental Immunology and Imaging, University Hospital Essen, University of Duisburg-Essen, Essen, 45141 Essen, Germany.
  • Department of Hematology and Stem Cell Transplantation, West-German Cancer Center, University Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany.
  • Computational Hematology Lab, Institute for Artificial Intelligence in Medicine, University Hospital, University of Duisburg-Essen, 45122 Essen, Germany.
  • Department of Infectious Diseases, West German Center of Infectious Diseases, University Hospital Essen, Hufelandstr. 55, University of Duisburg-Essen, 45122 Essen, Germany.
  • Department of Hematology and Oncology, Marienhospital University Hospital, Ruhr-University Bochum, 44721 Bochum, Germany.
  • ISAS Leibniz-Institut für Analytische Wissenschaften, Otto-Hahn-Str. 6b, 44227 Dortmund, Germany.

ORCID-Profile: Matthias Gunzer, Amin T Turki

Förderung

  • Deutsche Forschungsgemeinschaft
  • Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
  • Der Regierende Bürgermeister von Berlin, Senatskanzlei Wissenschaft und Forschung.ˮ
  • Projekt DEAL

Zitieren

APA

Cibir, Z., Beer, A., Kraus, A., Pillibeit, A., Bludau, D., Abdulla, H., Neuendorff, N. R., Sonneck, J., Kowitz, L., Riese, S., Tuz, A. A., Chen, J., Cherneha, M., Beelen, D. W., Reinhardt, H. C., Gunzer, M., & Turki, A. T. (2025). Risk beyond neutropenia: insights into neutrophil migration from newly diagnosed AML until late after allogeneic stem cell transplantation. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae250

Vancouver

Cibir Z, Beer A, Kraus A, Pillibeit A, Bludau D, Abdulla H, et al. Risk beyond neutropenia: insights into neutrophil migration from newly diagnosed AML until late after allogeneic stem cell transplantation. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae250

BibTeX
@article{Cibir2025,
  author = {Cibir, Zülal and Beer, Alexander and Kraus, Andreas and Pillibeit, Aleksandra and Bludau, Dana and Abdulla, Haji and Neuendorff, Nina Rosa and Sonneck, Justin and Kowitz, Lennart and Riese, Stefanie and Tuz, Ali Ata and Chen, Jianxu and Cherneha, Maxim and Beelen, Dietrich W and Reinhardt, H Christian and Gunzer, Matthias and Turki, Amin T},
  title = {Risk beyond neutropenia: insights into neutrophil migration from newly diagnosed AML until late after allogeneic stem cell transplantation},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiae250}
}
Kostenlos starten →